Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

The associations between plasma letrozole concentrations and CYP2A6 and CYP3A5 genetic variants were tested in the Exemestane and Letrozole Pharmacogenomics (ELPH) trial. ELPH is a multicenter, open-label prospective clinical trial in women randomly assigned (n ≈ 250 in each arm) to receive 2 years...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Desta, Z, Kreutz, Y, Nguyen, AT, Li, L, Skaar, T, Kamdem, LK, Henry, NL, Hayes, DF, Storniolo, AM, Stearns, V, Hoffmann, E, Tyndale, RF, Flockhart, DA
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667657/
https://ncbi.nlm.nih.gov/pubmed/21975350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi